Error
xxx
Welcome to the European Forum for Good Clinical Practice
Activities  >  Events and Activities  >  COVID-19 - Back to the Future Part II: CT Methodology. What was acceptable during the Covid-19 pandemic but should NOT stay?
Webinar
COVID-19 - Back to the Future Part II: CT Methodology. What was acceptable during the Covid-19 pandemic but should NOT stay?
Quality and ethics experts respond to your questions from sponsor and site points of view.
10 May 2021 - 17:00-18:00 CESTAdd to calendar
Description
Description

Our Free of Charge weekly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.

    Back to the Future Part II: CT Methodology. What was acceptable during the Covid-19 pandemic but should NOT stay?

    Moderator: Mark Poulton, Poulton Quality Solutions

    Agenda:
  • Opening: Mark Poulton, Poulton Quality Solutions

  • Introduction:
  • Catherine Dove, Dove Quality Solutions
  • Seif Eddine Amara Madi, GSK
  • Beat Widler, Widler & Schiemann
  • Heather Sampson, University of Toronto


  • Panel and Plenary Discussion
    Panelists:
  • Louise Mawer, Mirabilitas
  • Hugh Davies, National Research Ethics Service, UK



  • It is important to ask your Questions Upfront so that the team can answer adequately, please submit your questions using the following link: Click Here


Ask us
If you have any question, send us an email to info@efgcp.eu
Follow us
Linkedin
Twitter
EFGCP
European Forum for Good Clinical Practice
Rue de Washington 40
B-1050 Brussels - Belgium
Tel : +32 2 732 87 83
TVA : BE 0457 666 685